Development of tripeptidyl farnesyltransferase inhibitors

Cited 7 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorHee Yoon Lee-
dc.contributor.authorJeong Hun Sohn-
dc.contributor.authorByoung-Mog Kwon-
dc.date.accessioned2017-04-19T08:58:59Z-
dc.date.available2017-04-19T08:58:59Z-
dc.date.issued2002-
dc.identifier.issn0960894X-
dc.identifier.uri10.1016/S0960-894X(02)00227-5ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/5814-
dc.description.abstractThe first example of tripeptide inhibitors of farnesyltransferase with sub-micromolar inhibition activity was developed based on the fact that CVFM is not a substrate for farnesyltransferase.-
dc.publisherElsevier-
dc.titleDevelopment of tripeptidyl farnesyltransferase inhibitors-
dc.title.alternativeDevelopment of tripeptidyl farnesyltransferase inhibitors-
dc.typeArticle-
dc.citation.titleBioorganic & Medicinal Chemistry Letters-
dc.citation.number12-
dc.citation.endPage1602-
dc.citation.startPage1599-
dc.citation.volume12-
dc.contributor.affiliatedAuthorByoung-Mog Kwon-
dc.contributor.alternativeName이희윤-
dc.contributor.alternativeName손정훈-
dc.contributor.alternativeName권병목-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry Letters, vol. 12, no. 12, pp. 1599-1602-
dc.identifier.doi10.1016/S0960-894X(02)00227-5-
dc.description.journalClassY-
Appears in Collections:
Division of Biomedical Research > Genome Editing Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.